Clinton Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-92,471
Closed -$7.15M 438
2018
Q1
$7.15M Sell
92,471
-5,816
-6% -$468K 0.77% 16
2017
Q4
$8.3M Buy
+98,287
New +$8.36M 0.73% 28
2017
Q3
Sell
-52,822
Closed -$4.35M 507
2017
Q2
$4.35M Buy
52,822
+10,914
+26% +$890K 0.44% 61
2017
Q1
$3.52M Sell
41,908
-109,182
-72% -$8.74M 0.2% 142
2016
Q4
$11.1M Buy
+151,090
New +$11.3M 0.65% 21
2016
Q3
Sell
-51,776
Closed -$4.08M 992
2016
Q2
$4.08M Sell
51,776
-771
-1% -$58K 0.18% 158
2016
Q1
$3.78M Sell
52,547
-28,941
-36% -$2.19M 0.23% 130
2015
Q4
$6.87M Buy
81,488
+19,818
+32% +$1.64M 0.56% 21
2015
Q3
$5.16M Buy
+61,670
New +$5.21M 0.49% 42
2015
Q1
Sell
-16,486
Closed -$1.14M 551
2014
Q4
$1.14M Buy
+16,486
New +$1.11M 0.35% 68
2013
Q4
Sell
-14,358
Closed -$723K 365
2013
Q3
$723K Sell
14,358
-3,493
-20% -$183K 0.22% 120
2013
Q2
$877K Buy
+17,851
New +$971K 0.29% 50

Other funds holding LLY

Clinton Group's LLY Position: Q2 2018 in Review

Clinton Group sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 92,471 shares — an estimated $7.15M sold.

Clinton Group first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $11.1M in Q4 2016. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Clinton Group reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • Clinton Group sold 92,471 Eli Lilly shares in Q2 2018, an estimated $7.15M.
  • Clinton Group first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
  • Clinton Group's Eli Lilly position peaked at $11.1M in Q4 2016.
  • 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Clinton Group's 13F filing for Q2 2018, filed 6 Jul 2018.